Pharmaceutical
| Wed 01 Apr 2026
Alexandria, April 2 -- United States Patent for IGF2BP2 Inhibitors and Uses Thereof has been issued to City of Hope. This invention was developed by Chen Jianjun, Weng Hengyou, Huang Huilin, Horne David, Ma Yuelong, Li Hongzhi and Deng Xiaolan.
The patent application number is US202117794922 20210127. The patent publication n..